Zobrazeno 1 - 10
of 273
pro vyhledávání: '"Shi Ming Tu"'
Autor:
Joseph A. Moore, Michael J. Lehner, Simone Anfossi, Saumil Datar, Rebecca S. Tidwell, Matthew Campbell, Amishi Y. Shah, John F. Ward, Jose A. Karam, Christopher G. Wood, Lois L. Pisters, George A. Calin, Shi‐Ming Tu
Publikováno v:
BJUI Compass, Vol 4, Iss 1, Pp 81-87 (2023)
Abstract Objectives To investigate the utility of a novel serum miRNA biomarker panel to distinguish teratoma from nonmalignant necrotic/fibrotic tissues or nonviable tumours in patients with NSGCT undergoing post‐chemotherapy consolidation surgery
Externí odkaz:
https://doaj.org/article/4fdcd3926f9d47d19bbfd8f80ed57502
Autor:
Apostolia Maria Tsimberidou, David S. Hong, Siqing Fu, Daniel D. Karp, Sarina Piha-Paul, Merrill S. Kies, Vinod Ravi, Vivek Subbiah, Sunil M. Patel, Shi-Ming Tu, Filip Janku, John Heymach, Amber Johnson, Carrie Cartwright, Li Zhao, Jianhua Zhang, Donald A. Berry, David J. Vining, Andrew Futreal, Vincent A. Miller, Funda Meric-Bernstam
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-9 (2021)
Abstract Precision medicine is associated with favorable outcomes in selected patients with cancer. Herein, we report an interim analysis of IMPACT2, an ongoing randomized study evaluating genomic profiling and targeted agents in metastatic cancer. P
Externí odkaz:
https://doaj.org/article/33315794ca1f4daf8eba5da8574c8e3f
Publikováno v:
Asian Journal of Andrology, Vol 23, Iss 4, Pp 357-362 (2021)
This study analyzed RNA expression of genes for three serum tumor markers, alpha fetoprotein (AFP), human chorionic gonadotropin (hCG), and lactate dehydrogenase (LDH), in patients with testicular germ cell tumors (TGCT) type 2. The gene AFP encodes
Externí odkaz:
https://doaj.org/article/b8d7e3ad6e2541989d7c73cba5267029
Autor:
Alexander Stevenson, Jianjun Gao, Pavlos Msaouel, Nizar Tannir, Mehmet Altan, Shi-Ming Tu, Michael Chisamore, Matthew Campbell, George Blumenschein, Xiuning Le, Frank Mott, Amishi Shah, Jordi Rodon, Imke Mulder
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/65788d10c73b4f708db79ac2f96cc8ca
Autor:
Vivek Subbiah, Linghua Wang, Sara Ahmed, Michael Frumovitz, Jing Gong, Chantale Bernatchez, Siqing Fu, Aung Naing, Funda Meric-Bernstam, Shubham Pant, Nizar Tannir, Renata Ferrarotto, Joud Hajjar, Shi-Ming Tu, Mingxuan Xu, Anas Alshawa, Bettzy Stephen, Matthew Campbell, David S Hong, Sarina A Piha-Paul, Jordi Rodon Ahnert, Apostolia M Tsimberidou, Daniel D Karp, Timothy A Yap, Rivka R Colen, Vinod Ravi, Camilo Jimenez, Kanwal P Raghav, Gauri R Varadhachary, Ecaterina E Ileana Dumbrava, Sarjeel H Sabir, Saria Khan, Jeane M Painter, Abulrahman Abonofal, Richard M Simon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Patients with advanced rare cancers have poor prognosis and few treatment options. As immunotherapy is effective across multiple cancer types, we aimed to assess pembrolizumab (programmed cell death 1 (PD-1) inhibitor) in patients with adv
Externí odkaz:
https://doaj.org/article/633cee93179a43e799cae34404daa006
Autor:
Joseph A. Moore, Michael J. Lehner, Simone Anfossi, Saumil Datar, Rebecca S. Tidwell, Matthew Campbell, Amishi Y. Shah, John F. Ward, Jose A. Karam, Christopher G. Wood, Lois L. Pisters, George A. Calin, Shi‐Ming Tu
Publikováno v:
BJUI Compass. 4:81-87
To investigate the utility of a novel serum miRNA biomarker panel to distinguish teratoma from nonmalignant necrotic/fibrotic tissues or nonviable tumours in patients with NSGCT undergoing post-chemotherapy consolidation surgery.We prospectively coll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a900f82f01631be932f40a28787bce0a
https://doi.org/10.1002/bco2.143
https://doi.org/10.1002/bco2.143
Autor:
Robert L. Satcher, Sue-Hwa Lin, Mary C. Farach-Carson, Daniel A. Harrington, Shi-Ming Tu, Gary E. Gallick, Yu-Chen Lee, Guoyu Yu, Song-Chang Lin, Jian H. Song, Kelsea M. Hubka, Mariane Martinez, Tianhong Pan
Differentiation of pre-osteoblast MC3T3-E1 cells in 3D hydrogel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::496b4b92cc1f4d84ad5c66a4f08dcb15
https://doi.org/10.1158/1535-7163.22508242.v1
https://doi.org/10.1158/1535-7163.22508242.v1
Autor:
Christopher J. Logothetis, Peter F. Thall, Patricia Troncoso, Wadih Arap, Paul Mathew, Amado J. Zurita, Nizar M. Tannir, Charles Ryan, Randall E. Millikan, Jeri Kim, Lance C. Pagliaro, Shi-Ming Tu, John C. Araujo, Sijin Wen, Paul G. Corn, Andrea L. Harzstark, Ana M. Aparicio
Supplementary Figure 1 - PDF file 90K, A heat-map based on a matrix with patient characteristics and C1-C7 as columns and patients as rows. The clustering of columns and rows are based on the Euclidean distances (root sum-of-squares of difference)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f93262cd9bbff8a638323e74e7b0baf9
https://doi.org/10.1158/1078-0432.22451667
https://doi.org/10.1158/1078-0432.22451667
Autor:
Christopher Logothetis, Patricia Troncoso, Eleni Efstathiou, Gary E. Gallick, Theocharis Panaretakis, Mark A. Titus, Sumankalai Ramachandran, Guocan Wang, Sue-Hwa Lin, Nora M. Navone, Shixia Huang, Kimal Rajapakshe, Cristian Coarfa, Ana M. Aparicio, Shi-Ming Tu, Sumit K. Subudhi, Amado J. Zurita, Lianchun Xiao, Graciela M. Nogueras-Gonzalez, Miao Zhang, Paul G. Corn
Purpose:Cabozantinib, an oral inhibitor of c-MET/VEGFR2 signaling, improved progression-free survival (mPFS) but not overall survival (OS) in metastatic castrate-resistant prostate cancer. We evaluated cabozantinib plus androgen deprivation therapy (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba5e827f18be49a85477896607d21a1
https://doi.org/10.1158/1078-0432.c.6529356
https://doi.org/10.1158/1078-0432.c.6529356
Autor:
Padmanee Sharma, Christopher J. Logothetis, Lloyd J. Old, Gerd Ritter, Vikas Kundra, Shi-Ming Tu, Derek Ng Tang, Nasser K. Altorki, Sacha Gnjatic
Purpose: Different vaccination strategies against the NY-ESO-1 antigen have been employed in an attempt to induce antitumor immune responses. Antigen-specific effector T-cell responses have been reported in a subset of vaccinated patients; however, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6565617c826203810782872f26806365
https://doi.org/10.1158/1078-0432.c.6517543.v1
https://doi.org/10.1158/1078-0432.c.6517543.v1